EULAR is committed to advancing excellence in rheumatology through the promotion of task forces dedicated to developing evidence-based recommendations. In line with EULAR’s core principles of equality, diversity, and inclusion, we invite applications from qualified individuals to participate in these initiatives.

Members of EULAR task forces are experienced investigators in rheumatology, representing key areas of focus including Quality of Care and Clinical Affairs (QoC), Research (RES), Health Professionals in Rheumatology (HPR), and PARE (People with Arthritis and Rheumatism in Europe). 

Individuals from EULAR member societies who wish to apply are invited to submit a one-page letter of interest via the online link provided on this webpage. The letter should briefly outline the applicant’s relevant expertise and motivation for joining the task force. 

The final selection of candidates will be made by the task force convenor, in accordance with the EULAR Standard Operating Procedures (SOPs, section 3.1: Task Force Composition) and the principles of equality, diversity, and inclusion. 

Selection will be guided by the following criteria: 

• Demonstrated experience and publications in the relevant field, including participation in other task forces. 
• Representation from key academic centres active in the respective field across Europe. 
• Inclusion of a sufficient number of experts identified through publications or clinical work whose activities are not primarily industry-sponsored. 
• Comprehensive expertise covering all aspects of the disease relevant to the recommendation’s scope. 
• Balanced geographical representation.

Please note: 

the EMEUNET, HPR and PARE internal processes for the selection of their mandatory slots of representatives in the Task Forces are not related to this specific EULAR Task Forces wide general applications Call and are managed directly by these communities. 

To apply as task force member please go to the project dedicated application’s links below.

Deadline to apply: Thursday 20 November 2025, 23.45 hrs (CET). 

Open calls

• QoC040 -Points to consider: Use of CAR-based therapies and T cell engagers in inflammatory rheumatic diseases, Marc Scherlinger/ Jerome Avouac     
  
  Apply here 
  

• QoC039-Update of the EULAR points to consider/recommendations for the use of Artificial Intelligence and Big Data in RMDs, Gerd Burmester/ Latika Gupta
  
  Apply here 
  

• QoC038-Implementing the updated EULAR recommendations for patient research partner involvement in research: the INSPIRE initiative (Implementing New Strategies for PRP Involvement in Research at EULAR), Muriel Elhai/ Krystel Aouad
  
  Apply here
  
  
• QoC037-EULAR recommendations for the management of gout: 2027 update, Abhishek Abhishek/ Richette Pascal
  
  Apply here
  
  
• QoC035-Piloting a Pragmatic Dissemination and Early Implementation Model for EULAR Recommendations/Points to Consider, Fernando Estevez-Lopez/ Nina Østerås/ Rafael Prieto-Moreno  
  
  Apply here